Royalty Report: Drugs, Medical, Device – Collection: 352092

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 15

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 15

Primary Industries

  • Drugs
  • Medical
  • Device
  • Biotechnology
  • Diagnostic
  • Cannabis
  • Pharmaceuticals
  • Consumer Goods
  • Retail & Leisure
  • Healthcare
  • Equipment
  • Tool
  • Packaging & Containers
  • Food
  • Beverages
  • Disease
  • Chemicals
  • Material Composite
  • Plastics & Rubber
  • Biodegradable
  • Software
  • Computers & Office Equipment
  • Internet
  • Security
  • Data Security
  • Networking

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 352092

License Grant
Assignor assigned its entire right, title, and interest in the Innovation to Assignee.

To the extent Assignee grants a license of the Innovation, or any part thereof, to any third party, and receives Revenue therefrom, then Assignee agrees to pay to Assignor a percentage of Revenue received in the aggregate by Assignee from all such licensees granting rights to the Innovation, distributed by Assignee.

License Property
Assignor assigned its entire right, title, and interest in the Assigned Patent Applications, inventions and improvements therein, and Letters Patent (referred to herein collectively as the “Innovation”) to Assignee via that certain Assignment  recorded with the United States Patent and Trademark Office on November 16, 2016 at reel and frame number 040337/0243.
Field of Use
Field of use is for the medical industry.

Assignee is a developer of rapid health information technologies.

IPSCIO Record ID: 352096

License Grant
Inventor has assigned the entire right, title, and interest in the Assigned Patent Applications, inventions and improvements therein, and Letters Patent (referred to herein collectively as the Innovation) to Assignee and to the extent Assignee grants a license of the Innovation, or any part thereof, to any third party, and receives Revenue therefrom, then Assignee agrees to pay to Assignor a percentage of Revenue received in the aggregate by Assignee from all such licensees granting rights to the Innovation, distributed by Assignee.
License Property
Assigned Patent Applications shall mean the Patent Applications listed.
Provisional Application No. 62/632,448
United States Application No. 16/612,472
Field of Use
Field of use is for the treatment of various diseases in the Medical industry.

IPSCIO Record ID: 3608

License Grant
Assignor, an individual, desires to sell, assign, transfer and convey to Assignee, its successors and assigns, Assignor's entire right, title and interest throughout the world in and to the Patent Application and patents issuing thereon to the full end of the term or terms of any said patents.
License Property
Assignor has made certain inventions relating to chimeric peptides.

Product shall mean all products, drugs, diagnostic reagents, diagnostic methods, therapeutic agents and therapeutic methods covered in whole or in part by a Valid Claim contained in any Patent.

Field of Use
Inventions and patent applications relate to the use of chimeric peptides for the treatment of Alzheimer’s disease.

IPSCIO Record ID: 28996

License Grant
With effect from the Commencement Date, Australian Assignor as beneficial owner of the Invention assigns to the Australian Assignee to hold absolutely its entire right, title and interest in and to the Invention, for agents in the treatment of skin wrinkles.
License Property
Assignor is the owner of Australian Provisional Patent Application PS0528, filed on 15 February 2002 – the invention titled Carbohydrate-based anti-wrinkle and tissue remodelling compounds.
Field of Use
Assignee wishes to purchase the rights to and commercialise the Invention.

IPSCIO Record ID: 26072

License Grant
Assignor shall grant to Assignee (i) the exclusive right to use, sell, market, develop or distribute the products.  Assignor is the holder, owner and possessor of certain rights, technologies, devices, know-how, proprietary information, clinical data, intellectual property, and other unique and valuable assets, tangible and intangible, which are useful in providing extracorporeal blood separation/filtering procedures, including, without limitation, rights under the Asahi Distributorship Agreement (as defined herein) and certain rights granted by the Unites States Food and Drug Administration and the United States Patent Office (the foregoing and any and all anticipated an unanticipated future rights of Assignor relating to the Foregoing are, collectively, the Proprietary Rights and Technologies).
License Property
PRODUCT I
         First filter     Plasmaflo OP-05W(L)
         Second filter    Rheofilter AR-2000

Product I means the set of the above first filter and second filter which are
used together.
                              
PRODUCT II
         Plasmaflo AP-05H(L)
         Hemosorba CH-350

Field of Use
Disease shall mean any and all cell-mediated chronic inflammatory diseases, specifically, without limitation, Ulcerative Colitis, Crohn's Disease, Rheumatoid Arthritis and Multiple Sclerosis.

Market shall mean any and all treatment and/or research relating to the Disease.

IPSCIO Record ID: 738

License Grant
Entered into by and between the Denmark Assignor and the Assignee to acquire ownership of the Assigned Patents; and Assignor desires to obtain a certain license from Assignee to the Assigned Patents. As an inducement to Denmark Assignor to execute this Patent Assignment Agreement, Assignee hereby grants to Assignor a royalty-bearing, worldwide, exclusive (even as to Assignee) license (with the right to sublicense) to use the inventions, ideas and information embodied in the Assigned Patents to develop, make, use and sell products intended solely for use as reagents or products and methods intended solely for use in testing for and diagnosing conditions in humans, animals or organisms, as well as products and methods intended for predicting or testing the effect of treatment of Conditions in humans or animals.
License Property
The assigned Patents include Hydroxymethyl substituted RNA oligonucleotides and RNA complexes.
Field of Use
For use in testing for and diagnosing conditions in humans, animals or organisms.

IPSCIO Record ID: 221664

License Grant
Assignor, Assignee's largest shareholder, hereby sells, assigns, and transfers to Assignee and Assignee’s successors (a) all rights, title, and interests, to the Patent Application and all rights, title, and interests in any application and under any and all patents granted in the U.S. and abroad relating to the Patent Application, including but not limited to, all corresponding, provisional, continuation, continuation-in-part, divisional, reissue, and reexamination applications, for the entire term of the patent(s); (b) all rights, title, and interests in and to any and all foreign patents and applications for any invention described in the Patent Applications, in any and all countries foreign to the U.S., including all rights of priority arising from them, and all the rights and privileges under any and all forms of protection, including patents, that may be granted in said countries foreign to the U.S. for them for the entire term of the patent(s); and (c) the right to seek remedies for any and all infringements of any of the foregoing patents and to collect and retain all damages and profits and enjoy any and all remedies granted for infringements.

Assignee agrees to develop the Top-Shelf design into a working prototype and commence marketing, based on a timetable and a pre- approved cost structure, which shall be at the full discretion of the Assignee. Assignee shall have exclusive control over the timing, costs, sale and lease terms, marketing, development, and the rollout of Top Shelf product.

License Property
Assignor is the owner of the “Top Shelf” invention, as described in the United States Patent Application signed by Assignor on August 11, 2015, U.S. Patent and Trademark Office Serial Number 62/203,845, filed on August 11, 2015, and containing the following language (the Patent Application)

Apparatus for and method of securing, displaying, and dispensing herbal products including monitoring quantity and category of herbal products dispensed, and the persons who respectively dispensed and received each respective product.

The system allows for a dispensary operator to safely display product, secure product in an armored safe, weigh product in real-time using electronic scales housed in each of the locked compartments within the safe, and then dispense the product using an integrated Point-of-Sale, or POS System.

Assignor provides capital to our canna-business clientele and provide consulting services and technology to develop, enhance, and expand existing and newly formed canna-businesses.

Field of Use
This agreement pertains to the container industry relating to a apparatus for and method of securing, displaying, and dispensing herbal products.

IPSCIO Record ID: 26074

License Grant
Israelis ASSIGNOR hereby assigns to Israelis ASSIGNEE ASSIGNOR's entire right, title and interest under the Original License, including, without limitation, all ASSIGNOR's rights and licenses with respect to the LICENSED PRODUCT and the Licensed Patents and Know-How, as well as ASSIGNOR's entire right, title and interest in and to the name 'Cellscan'.

An exclusive worldwide right and license to use the Know-How and the Tooling and Test Equipment to Manufacture, Sell, and Support the Licensed product;

A non-exclusive worldwide right and license to use the Know-How and the Tooling and Test Equipment in the design and development of improvements to the Licensed product; and

An exclusive worldwide right and license to use the Know-How and Tooling and Test Equipment to design, Manufacture, Sell and Support any derivative of the Licensed which has a blood-related medical application or use.

License Property
'LICENSED PRODUCT' shall mean the 'Cellscan System'.
The CellScan system is a detection and monitoring system for human cells which may have many potential applications relating to disease diagnostics and determining chemosensitivity.

IPSCIO Record ID: 7335

License Grant
Assignor hereby assigns, and transfers unto Hong Kong Assignee The entire right, title and interest in the Patent Properties and in the corresponding inventions and in all subsequent divisions and continuations, or reissues or extensions thereof and in all patents issuing thereon in the United States or foreign countries, and in all corresponding patent applications filed in countries foreign to the United States, and in all patents issuing thereon in said foreign countries.

The right to file foreign patent applications on said invention in its own name, wherever such right may be legally exercised, including the right to claim the benefits of the International Convention for such applications.

License Property
7798MYl/PM/IAN/tam, Bandage based pain control through the delivery of electric impulses to the body.

IPSCIO Record ID: 25890

License Grant
The Licensor assigned the patent rights relating to International Patent Application No. PCT/IB2012/001470 to the Licensee of in Hong Kong.  Licensor is the beneficial stockholder of Licensee.
License Property
International Patent Application No. PCT/IB2012/001470 entitled Pain Management Device.

IPSCIO Record ID: 6480

License Grant
The Assignee wishes to acquire all interest in and to a License Agreement made on June 1, 2009.  The Assignor acquired rights to a bottle capping device called the Gas Cap.
License Property
The Gas Cap is bottle cap closure that allows the consumer to inject the liquid in the bottle with active ingredients, flavors, or vitamins. You simply twist the cap, and you can add a variety of flavors to your bottled water.
Field of Use
Field shall mean the bottle industry.

IPSCIO Record ID: 28713

License Grant
Assignee desires to acquire said patents for use within the Field of Use, both domestically and internationally.The Assignee is a stockholder of the Assignor/ Licensor.

The Company entered into a definitive Agreement pursuant to which the Licensor agreed to assign its ownership of 11 patents to the Company which protect the Licensor's infectious disease diagnostic test kit technology. The Licensor also granted the Company a License to utilize 18 additional patents related to the diagnostic test kits.

License Property
#5,989,902 Method for determining the antimicrobial agent sensitivity of a nonparaffinophilic hydrophobic microorganism and an associated apparatus
#5,981,210 Method for determining a presence or absence of a nonparaffinophilic hydrophobic microorganism in a body specimen by using a DNA extraction procedure and a novel DNA extraction procedure
#5,935,806 Method and apparatus for speciating and identifying MAI (Mycobacterium Avium Intracellulare) and testing the same for antibiotic sensitivity
#5,882,920 Apparatus for determining the presence or absence of a paraffinophilic microorganism
#5,854,014 Apparatus for testing paraffinophilic microorganisms for antimicrobial sensitivity
#5,846,760 Method for determining a presence or absence of a nonparaffinophilic hydrophobic microorganism in a body specimen and an associated kit
#5,776,722 Method of testing a body specimen taken from a patient for the presence or absence of a microorganism a further associated method and associated apparatus
#5,569,592 Apparatus for testing MAI (Mycobacterium Avium Intracellulare) for antimicrobial agent sensitivity
#5,472,877 Apparatus for determining the presence or absence of MAI (Mycobacterium Avium Intracellulare)
#5,316,918 Method and apparatus for testing MAI (Mycobacterium Avium Intracellulare) for antimicrobial agent sensitivity
#5,153,119 Method for speciating and identifying MAI (Mycobacterium Avium Intracellulare)
Field of Use
Assignee’s Field of Use or Field of Use with regard to Assignee’s use of the Assigned Patents and use of the technology and intellectual property associated with the Assigned Patents shall mean only the uses within the areas of health described herein; specifically, the detection and identification of human and veterinary identification of Atypical Mycobacteria, Tuberculosis, Mycobacterium Avium Intracellulare (MAI), Mycobacteria, Paratuberculosis, Nocardia and Pseudomonas for disease identification, and antibiotic assaying (but such assaying does not include antibiotic assaying when those antibiotics or compounds are derived from by-products obtained through growing microorganisms using Assignor's IP) for determining the antimicrobial agent sensitivity of microorganisms to ascertain which antibiotics are efficacious against microorganisms in the field of health which may lead to drug discoveries; and excludes any other uses, including any use reserved for the Assignor as specified in the Realm of Use or Assignor’s Use, and excludes kits for any other uses, which uses or kits are reserved to Assignor, including but not limited to uses, kits, or bioreactors pertaining to bioremediation, apoptosis, nanotechnology, biomems, microfluidic devices, the production of hydrogen and the identification and growing of over 32 different paraffin-eating and non-paraffin eating microorganisms to collect any microbial by-products of any kind, including antibiotics (all of which fall under the Realm of Use of the Assignor). Further, the Assignee’s Field of Use does not include any industrial use of the Assigned Patents. Whereas the Assignee’s Field of Use and the Assignor’s Use both provide for certain uses within the area of health, the Assignee, with regard to Assignee’s use of the Assigned Patents and use of the technology and intellectual property associated with the Assigned Patents is limited to only the uses within the areas of health that are specified in the Assignee’s Field of Use.

Realm of Use or Assignor’s Use with regard to the Assignor’s use of the Assigned Patents means the Assigned Patents and use of the technology and intellectual property associated with the Assigned Patents for all uses, including but not limited to (a) hydrogen production applications (b) augmenting growth of microorganisms to collect any microbial by-products, including but not limited to hydrogen, antibiotics, or any chemical synthesis (c) bioremediation (d) apoptosis (e) nanotechnology, (f) biomems for all uses, including but not limited to medical uses, (g) microfluidic devices for all uses, including but not limited to medical uses, and (h) identification and detection of over 32 different paraffin-eating and non-paraffin-eating microorganisms, other than for the identification of Atypical Mycobacteria, Tuberculosis, Mycobacterium Avium Intracellulare (MAI), Mycobacteria, Paratuberculosis, Nocardia and Pseudomonas for disease diagnosis (unless associated with biomems, microfluidic devices, or nanotechnology), (i) testing for antimicrobial agent sensitivity of microorganisms including but not limited to using such technology for controlling growth of undesirable microorganisms in a bioreactor and using such technology to test the efficacy of antibiotic compounds or other compounds which may be collected as by-products from using the Assigned Patents to identify and grow microorganisms, (j) any industrial use whatsoever; but excludes using the Assigned Patents and associated technology and intellectual property for (1) the detection and identification of human and veterinary identification of Atypical Mycobacteria, Tuberculosis, Mycobacterium Avium Intracellulare (MAI), Mycobacteria, Paratuberculosis, Nocardia and Pseudomonas for disease identification test kits (unless associated with biomems, microfluidic devices, or nanotechnology) and (2) selling test kits or providing diagnostic services in the field of health for determining the antimicrobial agent sensitivity of microorganisms to ascertain which antibiotics are efficacious against microorganisms in the field of health (unless associated with biomems, microfluidic devices, or nanotechnology). Whereas the Field of Use and the Realm of Use both provide for certain uses within the area of health, the Assignee, with regard to the Assigned Patents and all technology and intellectual property associated with the Assigned Patents is limited to only the uses within the areas of health that are specified in the Field of Use.

IPSCIO Record ID: 28297

License Grant
Irish Assignor hereby grants and the Assignee accepts the Assignment of Patent.
License Property
This agreement provided rights to the biodegradable plastics.

Assignor is the owner of United States Patent – 5,948,848 a patent for Biodegradable plastics – material and a method for its manufacture.

IPSCIO Record ID: 28282

License Grant
Assignor hereby assigns to Licensee, asubsidiary, all of Assignor's right, title and interest in and to both the tangible and the intangible property constituting the Intellectual Property, and transfers the Equipment.
License Property
Assignor is the owner of certain intellectual property, relating to data encryption and filtering.

U.S. Patent Application No. 09/438.973 titled 'Method and System for Data Encryption and Filtering' filed on October 21, 1999.

All office equipment including but not limited to Computers, Telephones, Fax and copy machines, all furniture, etc.

IPSCIO Record ID: 28113

License Grant
Pursuant to an assignment agreement between the parties, of the same date, Assignor has agreed to sell and assign, and Assignee has agreed to purchase and assume, the Assigned Assets.

Assignee shall have the sole right, but not the obligation, to protect all intellectual property rights related to the p-MPA Technology or the Products, by obtaining and maintaining appropriate patent, trademark, trade secret or other rights. Assignor agrees to cooperate, at the expense of Assignee, in the filing and prosecution of patent applications in the United States and in foreign countries in connection with all such intellectual property rights, and to promptly notify Assignee of any conflicting uses of, or any applications or registrations to use, any mark, name, symbol, device or word that becomes known to Assignor that Assignee believes may constitute an act of infringement with respect to the intellectual property rights related to p-MPA Technology or the Products.

Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.